Treatment of chronic urticaria;Therapie der chronischen urtikaria

Allergologie

Volumn 24, Issue 10, 2001, Pages 491-502

  Merk, H F ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Antihistamines; DADPS; Glucocorticoids; IVIG; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM ANTAGONIST; CETIRIZINE; CHLOROQUINE; CYCLOSPORIN A; DESLORATADINE; FEXOFENADINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; LEVOCETIRIZINE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CHRONIC URTICARIA; DRUG INDUCED DISEASE; DRUG RESEARCH; HUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW;

EID: 0034783170     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Highly potent and selective ligands for histamine H3-receptors
2. Comparison of fexofenadine (F), terfenadine (T), loratadine (L), and placebo (P) in a double-blind crossover trial utilizing a skin test model to examine suppression of histamineinduced wheal and flare
3. Treatment of severe chronic urticaria with cyclosporin
4. Succesful treatment of delayed pressure urticaria with montelukast
5. Definition and antagonism of histamine H2 receptors
6. Rezidivierende angioódeme dutch Cl-inhibitor-mangel: Erstickungsrisiko
7. Action protectrice des ethers phenoliques an cours de l'intoxication histaminique
8. The treatment of glucocorticoid-dependent chronic urticaria with stanazolol
9. Therapy of chronic idiopathic urticaria with nifedipine: Demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial
10. The effect of azelastine on neutrophil and eosinophil generation of superoxide
11. Die wirkung von ketotifen bei der urticaria factitia und der urticaria cholinergica im gekreuzten doppelblindversuch
12. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction
13. The spectrum of urticaria
14. Zafirlukast (Accolate) in the treatment of chronic idiopathic urticaria - A case series
15. Non-H1-receptor effects of antihistamines
16. Non-H1-receptor effects of antihistamines
17. The effect of H1 and H2 receptor antagonists on the dermographic response
18. Cimetidine in chronic idiopathic urticaria: A randomized double-blind study
19. The physiological action of B-imidazolylethylamine
20. Further observations on the action of B-imidazolylethylamine
21. Sensory responses of human skin to synthetic histamine analogues and histamine
22. Neue perspektiven in der modulation der allergischen entzündung
23. Chemical differentiation of histamine H1 and H2 receptor agonists
24. Successful treatment of chronic urticaria with leukotriene antagonists
25. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema
26. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria
27. Treatment of severe chronic urticaria with dapsone
28. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema
29. Antihistamines, drowsiness, and psychomotor impairment: Central nervous system effect of ceterizine
30. Plasmapheresis for severe, unremitting, chronic urticaria
31. Chronic urticaria
32. Histamine receptors in human skin: Indirect evidence
33. Urticaria and angioedema
34. Doubleblind cross-over study comparing doxepin with diphenhydramine for the treatment of chronic urticaria
35. Dermatological uses of high-dose intravenous immunoglobulin
36. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast
37. A controlled trial of therapy in chronic urticaria
38. Urticaria: Neue entwicklungen und perspektiven
39. Therapie der physikalischen urtikaria: Antihistaminika und alternativen
40. The characteristics of urticaria in 390 patients
41. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis and passive cutaneous anaphylaxis
42. The intradermal effects of the H3 receptor agonist Rα methylhistamine in human skin
43. Evaluation and treatment of urticaria
44. Treatment of chronic urticaria with a beta-2-adrenergic stimulant
45. The physical urticarias
46. Die entwicklung neuer strategien der urtikariatherapie als ein ergebnis klinisch orientierter forschung
47. The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine
48. Vascular reactions to histamine and compound 48/80 in human skin: Suppression by a histamine H2-receptor blocking agent
49. A comparison of hydroxyzine pamoate with chlorpheniramine in the treatment of dermographism
50. The effect of H1 and H2 histamine antagonists on symptomatic dermographism
51. Hypocomplementemia with cutaneous vasculitis and arthritis
52. Urticaria und angioödem
53. Fortschritte in verständnis und therapie allergischer sofortreaktionen mit antihistaminika
54. Histamine release in cold urticaria - Effect of ketotifen and oxatomide
55. Standard treatment: The role of antihistamines
56. Urticaria
57. Mast cells
58. Evidence that histamine is the causative toxin of scombroid-fish poisoning
59. Acute urticaria in infancy and early childhood. A prospective study
60. Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria
61. The metabolic profile of second-generation antihistamines
62. Synergistic effects of combined pentoxyfylline and dapsone in leukocytoclastic vasculitis
63. Familial urticaria. Investigation of a family and response to stanazol
64. Clinical pharmaco-kinetics of H1-receptor antagonists (the antihistamines)
65. Urtikaria-therapie mit H1- und H2-antihistaminika
66. Fexofenadine HCl in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study
67. Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers
68. Pharmacological influence of anti-allergic medication on in vivo allergen testing
69. Histamine, H1 and H2 antihistamines and immediate hypersensitivity reactions
70. The natural history and response to therapy of chronic urticaria and angioedema
71. The metabolism of antihistamines and drug interactions: The role of cytochrome P450 enzymes
72. Tricyclic antidepressants and histamine H1 receptors
73. Histamine and allergic diseases
74. Dapsone in the treatment of lupus erythematosus
75. Indikation und auswahl der arzneitherapie bei urticaria
76. Antiallergische und antientzündliche pharmakotherapie
77. Mast cellstheir role in urticaria
78. The role of cyproheptadine in the treatment of cold urticaria
79. Antihistamines (H1- and H2-receptor antagonists) in skin diseases
80. Clinical pharmacology of new histamine H1 receptor antagonists
81. Second-generation antihistamines
82. Terbutaline in the treatment of chronic urticaria
83. Antileukotrienes in chronic urticaria
84. Pharmacotherapy
85. Mediatorenmechanismen in der menschlichen haut. Pharmakoanalyse und therapeutische aspekte
86. Pharmacologic modulation of the whealing response to histamine in human skin: Identification of doxepin as a potent in vivo inhibitor
87. Treatment of urticaria: Medications other than antihistamines
88. Cardiac ion channels and antihistamines: Possible mechanisms of cardiotoxicity
89. The Clinical efficacy of antihistamines in the skin
90. Lowdose cyclosporin A in the treatment of severe chronic idiopathic urticaria
91. Urticarial vasculitis
92. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression - Inhibitory effects of anti-inflammatory drugs
93. New findings in pharmacological effects induced by antihistamines: From PET-studies to knock-out mice